Physician profile
Bertrand Bodo
NPI 1013379304
$1,041.27
in general payments reported to CMS, 2019-2025
13 companies · $242 in 2025
The $242 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $226 · 2022: $14.54 · 2023: $239 · 2024: $320 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $801.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $207.12 | 2021-2024 | |
| Globus Medical, INC. | $168.11 | 2024 | Harvest |
| Dynasplint Systems INC. | $139.86 | 2021 | |
| Vericel Corporation | $126.45 | 2025 | Maci |
| Stryker Corporation | $83.54 | 2023-2024 | Microfx Ocd, Iconix |
| Rattan and Associates | $75.90 | 2025 | |
| Orthofix Medical, INC. | $60.16 | 2024-2025 | Physio-Stim |
| Pacira Pharmaceuticals Incorporated | $42.43 | 2024-2025 | Exparel, Zilretta, Iovera |
| Depuy Synthes Sales INC. | $32.96 | 2022-2023 | Monovisc |
| Kowa Pharmaceuticals America, INC. | $32.91 | 2023 | Seglentis |
| Merck Sharp & Dohme LLC | $32.49 | 2021-2025 | Bridion |
| Nalu Medical, INC. | $19.84 | 2023 | Nalu Neurostimulation System |
| Abbott Laboratories | $19.50 | 2024 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bertrand Bodo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.